Viratek Inc.: The Costa Mesa pharmaceutical development...
Viratek Inc.: The Costa Mesa pharmaceutical development company reported first-quarter earnings of $405,000 for its fiscal 1991 year, up from earnings of $182,000 in the year-earlier period. Revenue for the quarter ended Feb. 28 was $1.4 million, up 17% from $1.2 million.
More to Read
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.